Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Current Medicinal Chemistry

• Publication date

  2010-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/092986710790980005PMID 20166921PMCID PMC4120766
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of intracellular carriers for the endocannabinoid anandamide

  2009cited by this paper
• Synthesis and characterization of a peripherally restricted CB1 cannabinoid antagonist, URB447, that reduces feeding and body-weight gain in mice.

  2009cited by this paper
• The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation.

  2009cited by this paper
• Dual Role of the Second Extracellular Loop of the Cannabinoid Receptor 1: Ligand Binding and Receptor Localization

  2009cited by this paper
• New resorcinol-anandamide "hybrids" as potent cannabinoid receptor ligands endowed with antinociceptive activity in vivo.

  2009cited by this paper
• Atypical Responsiveness of the Orphan Receptor GPR55 to Cannabinoid Ligands*

  2009cited by this paper
• Location, structure, and dynamics of the synthetic cannabinoid ligand CP-55,940 in lipid bilayers.

  2009cited by this paper
• Transmembrane helical domain of the cannabinoid CB1 receptor.

  2009cited by this paper
• The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist

  2008cited by this paper
• Conformational memories with variable bond angles

  2008cited by this paper
• Brain Neuronal CB2 Cannabinoid Receptors in Drug Abuse and Depression: From Mice to Human Subjects

  2008cited by this paper
• Signaling via CNS cannabinoid receptors.

  2008cited by this paper
• Endocannabinoid signaling as a synaptic circuit breaker in neurological disease

  2008cited by this paper
• Targeting the endocannabinoid system: to enhance or reduce?

  2008cited by this paper
• Residues accessible in the binding-site crevice of transmembrane helix 6 of the CB2 cannabinoid receptor.

  2008cited by this paper
• Targeting the endocannabinoid system: to enhance or reduce?

  2008cited by this paper
• CB1 cannabinoid antagonists: structure-activity relationships and potential therapeutic applications.

  2008cited by this paper
• 2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55.

  2008cited by this paper
• Ligand-binding architecture of human CB2 cannabinoid receptor: evidence for receptor subtype-specific binding motif and modeling GPCR activation.

  2008cited by this paper
• Lipid-mediated dimerization of β2-adrenergic receptor reveals important clues for cannabinoid receptors

  2008cited by this paper
• Structure of a β1-adrenergic G-protein-coupled receptor

  2008cited by this paper
• Binding mode prediction of conformationally restricted anandamide analogs within the CB1 receptor

  2008cited by this paper
• Enzymatic Machinery for Endocannabinoid Biosynthesis Associated with Calcium Stores in Glutamatergic Axon Terminals

  2008cited by this paper
• GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current

  2008cited by this paper
• Biarylpyrazolyl oxadiazole as potent, selective, orally bioavailable cannabinoid-1 receptor antagonists for the treatment of obesity.

  2008cited by this paper
• Conformationally constrained analogues of 2-arachidonoylglycerol.

  2007cited by this paper
• GPCR Structure-Based Virtual Screening Approach for CB2 Antagonist Search

  2007cited by this paper
• GPCR Engineering Yields High-Resolution Structural Insights into β2-Adrenergic Receptor Function

  2007cited by this paper
• Crystal structure of the human beta2 adrenergic G-protein-coupled receptor.

  2007cited by this paper
• High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor

  2007cited by this paper
• Crystal structure of the human β2 adrenergic G-protein-coupled receptor

  2007cited by this paper
• Mutation Studies of Ser7.39 and Ser2.60 in the Human CB1 Cannabinoid Receptor: Evidence for a Serine-Induced Bend in CB1 Transmembrane Helix 7

  2007cited by this paper
• Synthesis and biological evaluation of several structural analogs of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand.

  2007influential reference
• Identification of GPR55 as a lysophosphatidylinositol receptor.

  2007cited by this paper
• Hemopressin is an inverse agonist of CB1 cannabinoid receptors

  2007cited by this paper
• Biosynthetic Pathways of the Endocannabinoid Anandamide

  2007cited by this paper
• High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.

  2007cited by this paper
• A new receptor for cannabinoid ligands

  2007influential reference
• The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration.

  2007cited by this paper
• The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects

  2007cited by this paper
• The orphan receptor GPR55 is a novel cannabinoid receptor

  2007cited by this paper
• Biarylpyrazole inverse agonists at the cannabinoid CB1 receptor: importance of the C-3 carboxamide oxygen/lysine3.28(192) interaction.

  2006cited by this paper
• 3D-QSAR studies on cannabinoid CB1 receptor agonists: G-protein activation as biological data.

  2006cited by this paper
• Synthesis, conformational analysis and CB1 binding affinity of hairpin‐like anandamide pseudopeptide mimetics

  2006cited by this paper
• Cannabinoid CB2/CB1 selectivity. Receptor modeling and automated docking analysis.

  2006cited by this paper
• Peripheral cannabinoid receptor, CB2, regulates bone mass.

  2006cited by this paper
• F200A substitution in the third transmembrane helix of human cannabinoid CB1 receptor converts AM2233 from receptor agonist to inverse agonist.

  2006influential reference
• Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes

  2006cited by this paper
• Synthesis and CB1 receptor activities of dimethylheptyl derivatives of 2-arachidonoyl glycerol (2-AG) and 2-arachidonyl glyceryl ether (2-AGE).

  2006cited by this paper
• Alpha-methylated derivatives of 2-arachidonoyl glycerol: synthesis, CB1 receptor activity, and enzymatic stability.

  2006cited by this paper
• Cannabinoid CB1 receptor recognition of endocannabinoids via the lipid bilayer: molecular dynamics simulations of CB1 transmembrane helix 6 and anandamide in a phospholipid bilayer

  2006cited by this paper
• WIN55212-2 Docking to the CB1 Cannabinoid Receptor and Multiple Pathways for Conformational Induction

  2006cited by this paper
• Synthesis, cannabinoid receptor activity, and enzymatic stability of reversed amide derivatives of arachidonoyl ethanolamide.

  2006cited by this paper
• FRET-based monitoring of conformational change of the beta2 adrenergic receptor in living cells.

  2006cited by this paper
• Triaryl bis-sulfones as a new class of cannabinoid CB2 receptor inhibitors: identification of a lead and initial SAR studies.

  2005cited by this paper
• The Conformation, Location, and Dynamic Properties of the Endocannabinoid Ligand Anandamide in a Membrane Bilayer*

  2005cited by this paper
• Triaryl bis-sulfones as cannabinoid-2 receptor ligands: SAR studies.

  2005cited by this paper
• (-)-7′-Isothiocyanato-11-hydroxy-1′,1′-dimethylheptylhexahydrocannabinol (AM841), a High-Affinity Electrophilic Ligand, Interacts Covalently with a Cysteine in Helix Six and Activates the CB1 Cannabinoid Receptor

  2005cited by this paper
• Homology models of the cannabinoid CB1 and CB2 receptors. A docking analysis study.

  2005cited by this paper
• Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing.

  2005cited by this paper
• Molecular dynamics simulations of the endocannabinoid N-arachidonoylethanolamine (anandamide) in a phospholipid bilayer: probing structure and dynamics.

  2005cited by this paper
• Cysteine residues in the human cannabinoid receptor: only C257 and C264 are required for a functional receptor, and steric bulk at C386 impairs antagonist SR141716A binding.

  2005cited by this paper
• High affinity electrophilic and photoactivatable covalent endocannabinoid probes for the CB1 receptor.

  2005cited by this paper
• Cysteine 2.59(89) in the Second Transmembrane Domain of Human CB2 Receptor Is Accessible within the Ligand Binding Crevice: Evidence for Possible CB2 Deviation from a Rhodopsin Template

  2005cited by this paper
• Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors

  2005cited by this paper
• Virtual screening of novel CB2 ligands using a comparative model of the human cannabinoid CB2 receptor.

  2005cited by this paper
• Structural Mimicry in Class A G Protein-coupled Receptor Rotamer Toggle Switches

  2004influential reference
• Development of a 3D model for the human cannabinoid CB1 receptor.

  2004cited by this paper
• 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells.

  2004cited by this paper
• The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure.

  2004cited by this paper
• Synthesis, biological properties, and molecular modeling investigations of novel 3,4-diarylpyrazolines as potent and selective CB(1) cannabinoid receptor antagonists.

  2004cited by this paper
• Synthesis and CB1 receptor activities of novel arachidonyl alcohol derivatives.

  2004cited by this paper
• Integrity of extracellular loop 1 of the human cannabinoid receptor 1 is critical for high-affinity binding of the ligand CP 55,940 but not SR 141716A.

  2003influential reference
• Ether‐linked analogue of 2‐arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species

  2003cited by this paper
• 3D structural model of the G‐protein‐coupled cannabinoid CB2 receptor

  2003cited by this paper
• Hemisynthesis and preliminary evaluation of novel endocannabinoid analogues.

  2003cited by this paper
• Activation of phosphoinositide 3-kinase/PKB pathway by CB(1) and CB(2) cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction.

  2003cited by this paper
• Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol-sensitive receptors.

  2003cited by this paper
• Homology model of the CB1 cannabinoid receptor: Sites critical for nonclassical cannabinoid agonist interaction

  2003cited by this paper
• An aromatic microdomain at the cannabinoid CB(1) receptor constitutes an agonist/inverse agonist binding region.

  2003cited by this paper
• Structure of bovine rhodopsin in a trigonal crystal form.

  2003cited by this paper
• 2-Arachidonoylglycerol Induces the Migration of HL-60 Cells Differentiated into Macrophage-like Cells and Human Peripheral Blood Monocytes through the Cannabinoid CB2 Receptor-dependent Mechanism*

  2003cited by this paper
• Cannabinoid CB2 Receptors and Fatty Acid Amide Hydrolase Are Selectively Overexpressed in Neuritic Plaque-Associated Glia in Alzheimer's Disease Brains

  2003cited by this paper
• The molecular logic of endocannabinoid signalling

  2003cited by this paper
• N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A) interaction with LYS 3.28(192) is crucial for its inverse agonism at the cannabinoid CB1 receptor.

  2002cited by this paper
• 1-Methoxy-, 1-deoxy-11-hydroxy- and 11-hydroxy-1-methoxy-Delta(8)-tetrahydrocannabinols: new selective ligands for the CB2 receptor.

  2002cited by this paper
• Conformational memories and the endocannabinoid binding site at the cannabinoid CB1 receptor.

  2002influential reference
• Structural Adaptations in a Membrane Enzyme That Terminates Endocannabinoid Signaling

  2002cited by this paper
• International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors

  2002cited by this paper
• Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.

  2002cited by this paper
• Agonist alkyl tail interaction with cannabinoid CB1 receptor V6.43/I6.46 groove induces a helix 6 active conformation

  2002cited by this paper
• Functional role of serine residues of transmembrane dopamin VII in signal transduction of CB2 cannabinoid receptor.

  2002influential reference
• Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol.

  2002cited by this paper
• Structure Calculation of Protein Segments Connecting Domains with Defined Secondary Structure: A Simulated Annealing Monte Carlo Combined with Biased Scaled Collective Variables Technique

  2002cited by this paper
• Functional role of internal water molecules in rhodopsin revealed by x-ray crystallography

  2002cited by this paper
• Brain monoglyceride lipase participating in endocannabinoid inactivation

  2002cited by this paper
• Design, synthesis and biological activity of rigid cannabinoid CB1 receptor antagonists.

  2002cited by this paper
• In vitro and in vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor.

  2001cited by this paper
• Ceramide: a new second messenger of cannabinoid action.

  2001cited by this paper
• Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells.

  2001cited by this paper

• Exploring the neuroprotective effects of phytocannabinoids on oxygen-glucose deprived neurons in an in vitro model of stroke

  2026cites this paper
• Sex-specific association between low oral doses of cannabidiol (CBD) and plasma concentration of anandamide (AEA), N-palmitoylethanolamine (PEA) and N-oleoylethanolamine (OEA) in healthy occasional cannabis users

  2026influential citation
• Age differences in endocannabinoid tone are ameliorated after recent cannabis use

  2026cites this paper
• Genetically Encoded CB2R-Based Fluorescent Sensor Enables Rapid Screening and Functional Assessment of Cannabinoid Modulators

  2026cites this paper
• Can cannabinoids alleviate behavioral symptoms in older adults with dementia? A systematic review.

  2025cites this paper
• Endocannabinoid System Regulation in Pyometra-Affected and Healthy Canine Uteri

  2025cites this paper
• Sex-Specific Responses to Cannabis Exposure: Implications for Behavior and Beyond.

  2025cites this paper
• The role of cannabinoid agonists and antagonists on folliculogenesis and evolutionary events in the mouse ovary

  2025cites this paper
• Cannabis and Veterinary Medicine.

  2025cites this paper
• Indazole partial agonists targeting peripheral cannabinoid receptors.

  2025cites this paper
• Variability of total THC in greenhouse cultivated dried Cannabis

  2025cites this paper
• Impact of O-H···π Hydrogen Bond on IR and NMR Parameters of Cannabidiol: Theoretical and Experimental Study

  2025cites this paper
• A review of cellular and molecular interactions between endocannabinoids and male fertility: Balancing beneficial and detrimental effects.

  2025cites this paper
• Psilocybin mitigates behavioral despair and cognitive impairment in treatment-resistant depression model using wistar kyoto rats

  2025cites this paper
• How THC works: Explaining ligand affinity for, and partial agonism of, cannabinoid receptor 1

  2025cites this paper
• Beyond the hype: a comprehensive exploration of CBD’s biological impacts and mechanisms of action

  2025cites this paper
• Bayesian Nonparametric Analysis of Residence Times for Protein-Lipid Interactions in Molecular Dynamics Simulations.

  2025cites this paper
• Role of the Endocannabinoid System in Fibromyalgia

  2025cites this paper
• Early psilocybin intervention alleviates behavioral despair and cognitive impairment in stressed Wistar rats.

  2025cites this paper
• Bayesian nonparametric analysis of residence times for protein-lipid interactions in Molecular Dynamics simulations

  2025cites this paper
• Chronic cannabis use is associated with alterations in resting-state cerebellar-cortical connectivity.

  2025cites this paper
• Cannabidiol and Parkinson's disease: Investigating receptor interactions and their therapeutic implications.

  2025cites this paper
• AGA Clinical Practice Update on Diagnosis and Management of Cannabinoid Hyperemesis Syndrome: Commentary.

  2024cites this paper
• “Elucidating the immunomodulatory role of endocannabinoids in intervertebral disc degeneration”

  2024cites this paper
• Dynamic Mechanism for Subtype Selectivity of Endocannabinoids

  2024cites this paper
• Interplay between cannabinoids and the neuroimmune system in migraine

  2024cites this paper
• Endocannabinoid concentrations in major depression: effects of childhood maltreatment and relation to hippocampal volume

  2024cites this paper
• Exploring the evolutionary trajectory and functional landscape of cannabinoid receptors: A comprehensive bioinformatic analysis

  2024cites this paper
• The Effects of Nicotine and Cannabinoids on Cytokines.

  2024cites this paper
• The role of fatty acid-binding protein 5 and 7 on locomotor, anxiety and social behavior: Interaction with NMDA signaling.

  2024cites this paper
• Endocannabinoids and Stress-Related Neurospsychiatric Disorders: A Systematic Review and Meta-Analysis of Basal Concentrations and Response to Acute Psychosocial Stress

  2024cites this paper
• In silico exploration of CB2 receptor agonist in the management of neuroinflammatory conditions by pharmacophore modeling

  2024cites this paper
• The Interaction of the Endocannabinoid Anandamide and Paracannabinoid Lysophosphatidylinositol during Cell Death Induction in Human Breast Cancer Cells

  2024cites this paper
• Validating the anti-lymphoma pharmacodynamic actions of the endocannabinoids on canine non-Hodgkin lymphoma.

  2023cites this paper
• Chronic wound-related pain, wound healing and the therapeutic potential of cannabinoids and endocannabinoid system modulation.

  2023cites this paper
• Towards a New Dynamic Interaction Model of Adolescent CUD Manifestation, Prevention, and Treatment: A Narrative Review

  2023cites this paper
• Exploring the Therapeutic Potential of Cannabinoid Receptor Antagonists in Inflammation, Diabetes Mellitus, and Obesity

  2023cites this paper
• Neuroinflammation in the Central Nervous System: Exploring the Evolving Influence of Endocannabinoid System

  2023cites this paper
• Cannabinoid receptor gene CNR1 is downregulated in subcortical brain samples and upregulated in blood samples of individuals with schizophrenia: A participant data systematic meta‐analysis

  2023cites this paper
• Prenatal delta-9-tetrahydrocannabinol exposure is associated with changes in rhesus macaque DNA methylation enriched for autism genes

  2023cites this paper
• Novel Topical Anandamide Formulation for Alleviating Peripheral Neuropathic Pain.

  2023cites this paper
• Discovery of 1,3-disubstituted pyrazole peripheral cannabinoid receptor partial agonists.

  2023cites this paper
• Chronic Cannabis Use is Associated with Altered Monocyte Phenotype, Immune Response, and Depression in Physically Active Individuals.

  2023cites this paper
• Endocannabinoids are potential inhibitors of glioblastoma multiforme proliferation.

  2023cites this paper
• Cannabinoids in neuroinflammatory disorders: Focusing on multiple sclerosis, Parkinsons, and Alzheimers diseases

  2023cites this paper
• Anandamide Reuptake Inhibitor (VDM11) as a Possible Candidate for COVID-19 Associated Depression; a Combination of Network Pharmacology, Molecular Docking and In Vivo Experimental Analysis

  2023cites this paper
• Standardized Cannabis Smoke Extract Induces Inflammation in Human Lung Fibroblasts

  2022influential citation
• Rapid treatments for depression: Endocannabinoid system as a therapeutic target.

  2022cites this paper
• Pan-phylum In Silico Analyses of Nematode Endocannabinoid Signalling Systems Highlight Novel Opportunities for Parasite Drug Target Discovery

  2022cites this paper
• Antidiabetic actions of GPR55 agonist Abn-CBD and sitagliptin in obese-diabetic high fat fed mice.

  2022cites this paper
• Understanding the Dynamics of the Structural States of Cannabinoid Receptors and the Role of Different Modulators

  2022cites this paper
• Molecular study of endo and phytocannabinoids on lipid membranes of different composition.

  2022cites this paper
• Pharmacognosy and Effects of Cannabinoids in the Vascular System.

  2022cites this paper
• Endocannabinoid signaling in the central nervous system

  2022cites this paper
• Immunomodulatory actions of cannabinoids: Clinical correlates and therapeutic opportunities for allergic inflammation.

  2022cites this paper
• Evaluating Allosteric Perturbations in Cannabinoid Receptor 1 by In Silico Single-Point Mutation

  2022cites this paper
• Neuropharmacology of Alcohol Addiction with Special Emphasis on Proteomic Approaches for Identification of Novel Therapeutic Targets

  2022cites this paper
• The Role of Cannabinoids in CNS Development: Focus on Proliferation and Cell Death

  2022cites this paper
• Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant

  2022cites this paper
• Perspectives on Challenges in Cannabis Drug Delivery Systems: Where Are We?

  2022cites this paper
• Sex-specific and social experience-dependent oxytocin–endocannabinoid interactions in the nucleus accumbens: implications for social behaviour

  2022cites this paper
• A Randomized, Triple-Blind, Comparator-Controlled Parallel Study Investigating the Pharmacokinetics of Cannabidiol and Tetrahydrocannabinol in a Novel Delivery System, Solutech, in Association with Cannabis Use History

  2022cites this paper
• Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Plasma Endocannabinoid Levels in Healthy Volunteers: A Randomized Double-Blind Four-Arm Crossover Study

  2022cites this paper
• Structure-Based Design, Optimization, and Development of [18F]LU13: A Novel Radioligand for Cannabinoid Receptor Type 2 Imaging in the Brain with PET.

  2022cites this paper
• Cannabinoids Reduce Extracellular Vesicle Release from HIV-1 Infected Myeloid Cells and Inhibit Viral Transcription

  2022cites this paper
• Role of the Endocannabinoid System in the Regulation of Intestinal Homeostasis

  2022cites this paper
• A CB2 Receptor Agonist Reduces the Production of Inflammatory Mediators and Improves Locomotor Activity in Experimental Autoimmune Encephalomyelitis.

  2022cites this paper
• Evaluation of cannabinoid receptors type 1–2 in periodontitis patients

  2022cites this paper
• Understanding the role of the CB1 toggle switch in interaction networks using molecular dynamics simulation

  2021cites this paper
• Untapped Potential: Therapeutically Targeting Eicosanoids and Endocannabinoids in the Lung

  2021cites this paper
• DAGLα Inhibition as a Non-invasive and Translational Model of Episodic Headache

  2021cites this paper
• Occurrence of Morpholine in Central Nervous System Drug Discovery

  2021cites this paper
• Cholesterol as a modulator of cannabinoid receptor CB2 signaling

  2021cites this paper
• Exercise in Treatment of Migraine Including Chronic Migraine

  2021cites this paper
• New paradigms for the treatment of lysosomal storage diseases: targeting the endocannabinoid system as a therapeutic strategy

  2021cites this paper
• Synthesis, Molecular Pharmacology, and Structure-Activity Relationships of 3-(Indanoyl)indoles as Selective Cannabinoid Type 2 Receptor Antagonists.

  2021cites this paper
• The Endocannabinoid, Anandamide, Acts as a Novel Inhibitor of LPS‐Induced Inflammasome Activation in Human Gastric Cancer AGS Cell Line: Involvement of CB1 and TRPV1 Receptors

  2021cites this paper
• GPCR_LigandClassify.py; a rigorous machine learning classifier for GPCR targeting compounds

  2021cites this paper
• The Physiology and Pharmacology of Diabetic Gastropathy Management

  2021cites this paper
• Biosynthesis of Nature-Inspired Unnatural Cannabinoids

  2021cites this paper
• The lipid biology of sepsis

  2021cites this paper
• Therapeutic Attributes of Endocannabinoid System against Neuro-Inflammatory Autoimmune Disorders

  2021cites this paper
• Synthesis, Characterization, and DFT Studies of N-(3,5-Bis(trifluoromethyl)benzyl)stearamide

  2021cites this paper
• Progesterone and anandamide diminish the inhibitory effect of zinc on mature human sperm.

  2021cites this paper
• Development of fluorinated and methoxylated benzothiazole derivatives as highly potent and selective cannabinoid CB2 receptor ligands.

  2021cites this paper
• Biased Coupling to β-Arrestin of Two Common Variants of the CB2 Cannabinoid Receptor

  2021cites this paper
• Cannabinoid receptor 2 selective agonists and Alzheimer's disease: An insight into the therapeutic potentials

  2021cites this paper
• Metabolic Consequences of Gestational Cannabinoid Exposure

  2021influential citation
• Endocannabinoids: Anandamide and 2-Arachidonoylglycerol (2-AG)

  2021cites this paper
• Amino Appended Coumarin Composites for Pb2+ Capturing in Aqueous Medium

  2021cites this paper
• Wonder or evil?: Multifaceted health hazards and health benefits of Cannabis sativa and its phytochemicals

  2021cites this paper
• Cannabinoids and Pain: Mechanisms of Action

  2021cites this paper
• Hemp Microgreen Mineral Content, Cannabinoids, Total Phenolics, and Antioxidants

  2021cites this paper
• Targeting the endocannabinoid system to treat skin melanoma: a systematic review

  2020cites this paper
• Antinociception mechanisms of action of cannabinoid-based medicine: an overview for anesthesiologists and pain physicians

  2020cites this paper
• Use of Cannabis for Self-Management of Chronic Pelvic Pain

  2020cites this paper
• New Insights Into Peptide Cannabinoids: Structure, Biosynthesis and Signaling

  2020cites this paper
• The Endocannabinoid System as Modulator of Exercise Benefits in Mental Health

  2020cites this paper
• Hemopressin as a breakthrough for the cannabinoid field.

  2020cites this paper
• Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors.

  2020cites this paper